U.S. Logistics Stock News

FedEx (NYSE:FDX) has completed the spin-off of its FedEx Freight unit. FedEx Freight is now a separate, publicly traded company with its own business strategy. The newly independent FedEx Freight has released its first stand-alone financial and strategic updates. For FedEx, this move reshapes how its core operations are organized across express, ground and less than truckload freight services. Investors now see FedEx Freight as a focused trucking business, while the remaining FedEx...

Earlier this month, Array Technologies filed a US$202.42 million shelf registration for 26,425,733 common shares tied to an ESOP-related offering and launched its DuraTrack D2S dual-row solar tracker, initially targeting the EMEA market with a first commercial project underway in Spain. The DuraTrack D2S rollout highlights how Array is tailoring its core tracker architecture to complex terrain and two-row layouts that many international utility-scale solar developers prefer. We’ll now...

In late June 2026, Relay Therapeutics, Inc. was added to multiple Russell growth benchmarks, including the Russell 3000 Growth, Russell 2000 Growth, Russell 2500 Growth, Russell 3000E Growth, and the Russell Small Cap Comp Growth indexes. This broad-based inclusion across several influential growth indexes can increase Relay Therapeutics’ visibility among institutional investors and index-tracking funds, potentially reshaping how the market views its role within the small- and mid-cap...

In late June 2026, Lumentum Holdings Inc. (NasdaqGS:LITE) was removed from several major Russell indices and value and growth benchmarks, potentially affecting index-linked ownership and liquidity. This extensive index exclusion contrasts with the company’s recent focus on AI-related optics and governance, highlighted by its June 2026 presentations at the Rome Conference on AI Ethics and Governance. Next, we’ll examine how Lumentum’s broad removal from key Russell indices may alter its...

Insulet (PODD) has just been added to both the Russell 2500 and Russell 2500 Growth indexes, a change that can influence institutional ownership as index funds align their holdings with the new benchmarks. See our latest analysis for Insulet. Insulet’s recent index additions follow a mixed price pattern, with a 7 day share price return of 5.87% and a 30 day share price return of 5.11%. However, the year to date share price return is down 46.15%, while the 1 year total shareholder return is...

U.S. federal appellate court rules that Ardelyx’s Xphozah will be included in Medicare’s ESRD bundled payment system, ending separate reimbursement. The decision resolves a long-running legal dispute over how the drug is treated under Medicare’s payment structure for dialysis care. The ruling affects how dialysis providers are paid for Xphozah and may influence pricing decisions and product positioning for NasdaqGM:ARDX. Ardelyx, the biopharmaceutical company behind Xphozah, focuses on...

Index-driven shift puts Veeco Instruments in the growth spotlight Veeco Instruments (VECO) has just been reclassified across multiple Russell indexes, moving into several growth benchmarks and exiting a range of value oriented indexes during the latest index rebalancing. This shift places Veeco Instruments more firmly in the growth bucket for index providers, which can influence how index funds and growth focused investors assess the stock and adjust their exposure. See our latest analysis...

On 27 June 2026, Clarivate Plc was moved out of the Russell 1000 and Midcap families and into the Russell 2000, including the Russell 2000 Value and Russell 2000 Dynamic indices. This index migration reshapes how passive funds and quant investors gain exposure to Clarivate, potentially changing trading volumes, liquidity patterns, and the shareholder base. Next, we’ll examine how Clarivate’s shift from Russell 1000 to Russell 2000 membership may influence its existing investment narrative...

Dividend growth stocks sit at an interesting crossroads for income investors who want more than just a static payout. When a company steadily lifts its dividend, it can signal confidence in its cash generation and a willingness to share that cash with shareholders. This article looks at how one recent news event may affect a select group of dividend growers, and what that could mean for your watchlist. Ahead, you will find three stocks from our Dividend Growth Stocks screener that appear...

In late June 2026, Navitas Semiconductor Corporation was removed from multiple Russell indexes and related growth and value benchmarks following the annual reconstitution process. At the same time, shareholders approved declassification of Navitas’ board so that all directors will stand for election together at the 2027 annual meeting, potentially increasing board accountability to investors. Next, we’ll examine how Navitas’ broad removal from Russell indexes could influence its investment...

Former President Trump disclosed a purchase of US$1 million to US$5 million in Axon Enterprise (NasdaqGS:AXON) stock. The filing shows the transaction occurred weeks before U.S. Immigration and Customs Enforcement issued a US$220 million Taser contract solicitation. The contract terms are reported to align closely with Axon’s product line, drawing attention from ethics specialists. Commentators are questioning whether the timing highlights gaps in the federal STOCK Act and conflict of...

Penguin Solutions (NasdaqGS:PENG) has been moved out of Russell value benchmarks and into several growth benchmarks. The company is now included in the Russell 2000, 2500, 3000, and Microcap Growth indices. This broad reclassification reflects a shift in how index providers classify Penguin Solutions within the market. Penguin Solutions, which focuses on data center and edge computing hardware and services, now sits in a different peer group inside the Russell index family. For investors...

Oracle (NYSE:ORCL) has introduced AI powered agentic applications within its Fusion Cloud Supply Chain & Manufacturing platform. The new tools aim to automate workflows such as inventory planning, supplier qualification, production readiness, and Kanban administration. The launch extends Oracle's use of embedded AI from core infrastructure into day to day enterprise supply chain operations. Oracle is pushing deeper into operational AI by bringing autonomous agents into its core supply chain...

In late June 2026, McKesson Corporation was added to the Russell 1000 Defensive, Russell 1000 Value-Defensive, and Russell 1000 Growth-Defensive indexes, while partner TempraMed expanded its distribution agreement with McKesson Medical-Surgical across North America to deepen access to temperature-controlled medication solutions. These developments highlight how McKesson is increasingly positioned as a core defensive healthcare distributor while extending its reach into specialized,...

On 27 June 2026, Rubrik, Inc. (NYSE:RBRK) was removed from the Russell 1000 Value-Defensive, Defensive, and Growth-Defensive indices, a change that can influence how index-tracking funds and benchmarked portfolios treat the stock. These index removals arrive just days after new AI governance collaborations with Amazon Bedrock AgentCore and Cognizant, highlighting a contrast between Rubrik’s product momentum and its shifting role in key equity benchmarks. We’ll now examine how Rubrik’s...

Why a proposed class action settlement matters for Oppenheimer Holdings Oppenheimer Holdings (OPY) is back in focus after Oppenheimer & Co. Inc. agreed to a proposed US$70,000,000 settlement in a class action lawsuit, with court approval scheduled to be considered in September 2026. See our latest analysis for Oppenheimer Holdings. The proposed settlement arrives at a time when Oppenheimer Holdings has seen a 30-day share price return of 15.13% and a year-to-date share price return of 45.29%...

BridgeBio Pharma has released previously announced positive Phase 3 PROPEL 3 data for oral infigratinib in children with achondroplasia, now published in the New England Journal of Medicine, showing statistically significant gains in annualized height velocity, body proportionality and arm span with a favorable safety profile. The company now plans to file regulatory applications in the US and EU starting in the third quarter of 2026, positioning oral infigratinib as a potential first...

Hinge Health (NYSE:HNGE) has been added to multiple major Russell indexes following its latest quarterly results. The index changes coincide with the company reporting strong quarterly performance. Hinge Health also raised its full year guidance around the same time as the Russell index inclusions. The combination of broader index exposure and updated outlook marks a key moment for the company’s public market profile. Hinge Health focuses on digital musculoskeletal care, an area that sits...

Index reshuffle puts fresh attention on nCino stock nCino (NCNO) is back in focus after a broad reshuffle of its index memberships, with the stock added to several Russell 2000 segments while being removed from multiple Russell 1000 and Midcap benchmarks. These shifts typically prompt passive index trackers to rebalance their holdings, which can influence trading volumes around the effective date and encourage active investors to reassess how nCino fits within small cap, growth, and value...

Index removals put Plexus stock in focus Plexus (PLXS) has been removed from several Russell value indices, including the Russell 2000 Value and Russell 3000 Value. This index reshuffle can influence trading as passive funds adjust positions. See our latest analysis for Plexus. The index removals come at a time when Plexus has seen strong momentum, with a 90 day share price return of 45.10% and a year to date share price return of 97.51%, while the 1 year total shareholder return sits at...

LPL Financial Holdings (LPLA) has just been added to several Russell value benchmarks, including the Russell 1000 Value and Russell 3000 Value indices. This shift can influence index-driven demand and attention. See our latest analysis for LPL Financial Holdings. The Russell index additions come after a mixed stretch for LPL Financial Holdings, with the share price rising 4.62% in the last day and 2.89% over 30 days, but declining 22.11% year to date. The 5 year total shareholder return sits...

In late June 2026, Apollo Commercial Real Estate Finance, Inc. (NYSE: ARI) was removed from multiple major equity indices, including the S&P Composite 1500, S&P SmallCap 600, S&P 1000 and several Russell growth and small‑cap benchmarks, following index reconstitutions. This broad index exclusion reduces automatic ownership by index‑tracking funds and could influence liquidity, trading patterns and how investors assess ARI within the listed mortgage REIT universe. We’ll now examine how ARI’s...

Why Semtech’s latest quarter matters for investors Semtech (SMTC) has just reported first quarter fiscal 2027 results that topped earnings expectations while guiding second quarter net sales higher, prompting analysts to revisit their assumptions about the company’s operating momentum and business outlook. For investors, this combination of an earnings beat and raised sales guidance typically shifts attention from short term trading moves toward how sustainably the underlying business is...

AI infrastructure has shifted from a niche theme to a major force in markets, as investors respond to headlines about Micron, Intel, AMD and other chip stocks adding trillions in combined market value. Instead of chasing every hype cycle, it can help to focus on companies with solid financial and market metrics that are directly exposed to this AI infrastructure build out. This article walks through 3 stocks from our AI Infrastructure Beneficiaries screener that appear positively exposed to...